rimondini roberto

Has grant

Associated Professor

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia
Country flagItaly

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Roberto Rimondini is an Associated Professor at the Università degli Studi di Bologna, Scuola di Medicina e Chirurgia, Italy. His research focuses on neurodegenerative diseases, the microbiota-gut-brain axis, and the effects of microRNAs on cell adhesion molecules. Recent publications include studies on impulse control disorders and the impact of voluntary running in mouse models related to CDKL5 deficiency and Fabry disease.

Recent Grants

Grant: Close

Characterization in mice of the role of gene X in the pathophysiological mechanisms of depression

Open Date: 2022-01-01

Close Date:

Grant: Close

Biomolecular and functional analysis of pathogenetic mechanisms of neuropathic pain in genetic and acquired small fibre neuropathies.

Open Date: 2011-01-01

Close Date: 2015-01-01

Grant: Close

New therapeutic strategies for Alzheimer's disease: induction of neural plasticity and mitochondria bolstering by the Rho GTPases' activator CNF1

Open Date: 2010-01-01

Close Date: 2012-01-01

Grant: Close

Studi struttura-funzione sulle neurotrofine e loro precursori nella funzione presinaptica, nella epilettogenesi e nella neurogenesi adulta”

Open Date: 2007-01-01

Close Date: 2009-01-01

Grant: Close

“Identification and validation of molecular targets for pharmacological treatment of alcohol dependence (TARGALC)”

Open Date:

Close Date:

Articles (12)

Year:

2024

Year:

2023

Year:

2023

In the brain, cell adhesion molecules (CAMs) are critical for neurite outgrowth, axonal fasciculation, neuronal survival and migration, and synapse formation and maintenance. Among CAMs, the IgLON family comprises five members: Opioid Binding Protein/Cell Adhesion Molecule Like (OPCML or OBCAM), Limbic System Associated Membrane Protein (LSAMP), neurotrimin (NTM), Neuronal Growth Regulator 1 (NEGR1), and IgLON5. IgLONs exhibit three N-terminal C2 immunoglobulin domains; several glycosylation sites; and a glycosylphosphatidylinositol anchoring to the membrane. Interactions as homo- or heterodimers in cis and in trans, as well as binding to other molecules, appear critical for their functions. Shedding by metalloproteases generates soluble factors interacting with cellular receptors and activating signal transduction. The aim of this review was to analyse the available data implicating a role for IgLONs in neuropsychiatric disorders. Starting from the identification of a pathological role for antibodies against IgLON5 in an autoimmune neurodegenerative disease with a poorly understood mechanism of action, accumulating evidence links IgLONs to neuropsychiatric disorders, albeit with still undefined mechanisms which will require future thorough investigations.

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Cecilia Delprete

IRCCS Istituto Delle Scienze Neurologiche di Bologna

ITALY
View details

Friederike Uhlig

University College Cork

IRELAND
View details

Emiliano Biasini

Assistant Professor

Università degli Studi di Torino

ITALY
View details

M. Caprini

University of Bologna

ITALY
View details

Giuseppe Galvani

University of Bologna

ITALY
View details

Zaira Maroccia

Istituto Superiore di Sanità

ITALY
View details

Stefania Trazzi

Professore Associato

-

ITALY
View details

Niall Hyland

University College Cork

IRELAND
View details

Lucia Carboni

ALMA MATER STUDIORUM UNIVERSITY OF BOLOGNA

ITALY
View details

Maurizio Giustetto

Associate Professor of Human Anatomy

Università degli Studi di Torino

ITALY
View details

GIORGIO AICARDI

Professore ordinario

University of Bologna

ITALY
View details

Elisabetta Ciani

University of Bologna

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.